Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Neuland Laboratories aggregated by PharmaCompass.com.

    Client Virtual Booth

    NEULAND LABORATORIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    • Difelikefalin

    • Empagliflozin

    • Ensifentrine

    • Fezolinetant

    • Mirabegron

    • Tapinarof

    • Tirzepatide

    • Vilanterol Trifenatate

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neuland VB RM
    Neuland Laboratories
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    11th Floor (5th Level), Phoenix IVY Building, Plot No. 573A-III, Road No. 82, Jubilee Hills, Hyderabad, 500033, Telangana
    Telephone
    Telephone
    +91 9849431936, +91 40 67611600 / 700
    Client Email
    Email
    marketing@neulandlabs.com
    Client Website
    Website
    https://www.neulandlabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuland-laboratories-limited/
    Twitter
    Twitter
    https://twitter.com/neulandlabs
    Contact Info
    Others

    Full View ScreenFull Screen View
    Neuland unveils refreshed brand identity
    Neuland unveils refreshed brand identity

    https://www.neulandlabs.com/blog/2024/06/07/redefining-excellence-neuland-unveils-a-refreshed-brand-identity-2024/

    PRESS RELEASE
    07 Jun 2024
    Share Share
    A Check-in on 2024 Trends in the CDMO Industry
    A Check-in on 2024 Trends in the CDMO Industry

    https://www.neulandlabs.com/blog/2024/05/02/from-the-neuland-reading-room-a-check-in-on-2024-trends-in-the-cdmo-industry/

    Saharsh Davuluri PRESS RELEASE
    02 May 2024
    Share Share
    Goldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab
    Goldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab

    https://www.moneycontrol.com/news/business/earnings/goldman-sach-initiates-buy-on-syngene-neuland-adds-sell-tag-to-larus-lab-12625281.html

    MONEYCONTROL
    11 Apr 2024
    Share Share
    How to Ensure Effective Technology Transfer to CDMOs
    How to Ensure Effective Technology Transfer to CDMOs

    https://www.neulandlabs.com/blog/2024/03/28/how-to-ensure-effective-technology-transfer-to-cdmos/

    Saharsh Davuluri PRESS RELEASE
    28 Mar 2024
    Share Share
    Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility
    Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility

    https://www.moneycontrol.com/news/business/markets/neuland-labs-zooms-5-on-us-fda-all-clear-for-hyderabad-facility-12509081.html

    MONEYCONTROL
    25 Mar 2024
    Share Share
    Why Agility Matters When Choosing an API Contract Manufacturing Partner
    Why Agility Matters When Choosing an API Contract Manufacturing Partner

    https://www.neulandlabs.com/blog/2024/03/04/why-agility-matters-when-choosing-an-api-contract-manufacturing-partner/

    Saharsh Davuluri PRESS RELEASE
    04 Mar 2024
    Share Share
    Neuland Laboratories Q3 & 9M FY24 Earnings Conference Call” February 09, 2024
    Neuland Laboratories Q3 & 9M FY24 Earnings Conference Call” February 09, 2024

    https://www.neulandlabs.com/wp-content/uploads/2024/02/Neuland-Laboratories-Limited-Q3FY24-Earnings-Call-Transcript.pdf

    PRESS RELEASE
    13 Feb 2024
    Share Share
    Board Meeting Outcome Unaudited Q3 FY2023-24 Financial Results
    Board Meeting Outcome Unaudited Q3 FY2023-24 Financial Results

    https://www.neulandlabs.com/wp-content/uploads/2024/02/SignedBMOutcome08022024.pdf

    PRESS RELEASE
    08 Feb 2024
    Share Share
    Neuland Q3FY24 income
    Neuland Q3FY24 income

    https://www.neulandlabs.com/wp-content/uploads/2024/02/Neuland-Laboratories-Limited-Q3FY24-Press-Release.pdf

    PRESS RELEASE
    08 Feb 2024
    Share Share
    API Particle Size Part 2: New & Emerging Technologies Impacting Particle Size
    API Particle Size Part 2: New & Emerging Technologies Impacting Particle Size

    https://www.neulandlabs.com/blog/2024/02/01/api-particle-size-part-2-new-emerging-technologies-impacting-particle-size/

    PRESS RELEASE
    01 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Neuland VB RM

    Peptide Therapeutics

    Exhibiting

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search